DONNA MATHIS: Open Payments
NPI 1467454413 · PRICE, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$509 in 26 payments from 13 companies in 2025. Trend: 2023 $435 · 2024 $513 · 2025 $509
Food & beverage: $509
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $114 |
| ABBVIE INC. | 4 | $100 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| Amgen Inc. | 2 | $39 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $37 |
| Neurocrine BioSciences, Inc. | 2 | $37 |
| Merck Sharp & Dohme LLC | 2 | $36 |
| SANOFI PASTEUR INC. | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| HARMONY BIOSCIENCES LLC | 1 | $17 |
Products named: VRAYLAR, AIRSUPRA, REXULTI, BREZTRI, EVENITY, Kerendia, INGREZZA, QULIPTA.
Industry payments across UT — which companies pay providers there.
